Literature DB >> 30803859

FXR deficiency alters bile acid pool composition and exacerbates chronic alcohol induced liver injury.

Bo Kong1, Min Zhang2, Mingxing Huang3, Dan Rizzolo4, Laura E Armstrong4, Justin D Schumacher4, Monica D Chow5, Yi-Horng Lee6, Grace L Guo7.   

Abstract

Recent studies have investigated the roles of FXR deficiency in the pathogenesis of alcoholic liver disease (ALD). However, the underlying molecular mechanisms remain unclear. In this study, FXR knockout (FXR-/-) and wild-type (WT) mice were subjected to chronic-plus-binge alcohol feeding to study the effect of FXR deficiency on ALD development. The degree of liver injury was greater in FXR-/- mice compared to WT mice. Ethanol feeding enhanced hepatic steatosis in FXR-/- mice, accompanied by decreased mRNA levels of Pparα and Srebp-1c. The expression of Lcn2 was increased by ethanol treatment, despite unchanged expression of pro-inflammatory cytokines Tnfα, Il6 and Il-1β. Furthermore, ethanol treatment altered bile acid (BA) homeostasis to a greater extent in FXR-/- mice, as well as serum and hepatic BA pool composition. The mRNA levels of hepatic Cyp7a1 and Shp, as well as intestinal Fgf15, were decreased in WT mice with ethanol feeding, which were further reduced in FXR-/- mice. Levels of both primary and secondary BAs were markedly elevated in FXR-/- mice, which were further increased after ethanol treatment. Moreover, hepatic MAPK signaling pathways were disturbed presumably by increased hepatic BA levels. In summary, FXR deficiency increased hepatic steatosis and altered BA pool composition, contributing to worsened liver toxicity.
Copyright © 2019 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alcoholic liver disease; Bile acid profile; Ethanol toxicity; Lipid metabolism; Liver steatosis

Mesh:

Substances:

Year:  2019        PMID: 30803859      PMCID: PMC6451669          DOI: 10.1016/j.dld.2018.12.026

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  16 in total

Review 1.  Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease.

Authors:  Tiangang Li; John Y L Chiang
Journal:  Hepatobiliary Surg Nutr       Date:  2020-04       Impact factor: 7.293

2.  Intestinal SIRT1 Deficiency Protects Mice from Ethanol-Induced Liver Injury by Mitigating Ferroptosis.

Authors:  Zhou Zhou; Ting Jie Ye; Elizabeth DeCaro; Brian Buehler; Zachary Stahl; Gregory Bonavita; Michael Daniels; Min You
Journal:  Am J Pathol       Date:  2019-10-11       Impact factor: 4.307

Review 3.  Farnesoid X receptor: a potential therapeutic target in multiple organs.

Authors:  Chao Zhang; Zixuan Wang; Qingqing Feng; Wei-Dong Chen; Yan-Dong Wang
Journal:  Histol Histopathol       Date:  2021-01-04       Impact factor: 2.303

Review 4.  New insights into the bile acid-based regulatory mechanisms and therapeutic perspectives in alcohol-related liver disease.

Authors:  Yali Liu; Tao Liu; Xu Zhao; Yanhang Gao
Journal:  Cell Mol Life Sci       Date:  2022-08-17       Impact factor: 9.207

5.  Transcriptomic Analysis Reveals Lactobacillus reuteri Alleviating Alcohol-Induced Liver Injury in Mice by Enhancing the Farnesoid X Receptor Signaling Pathway.

Authors:  Yonglang Cheng; Xin Xiang; Chen Liu; Tianying Cai; Tongxi Li; Yifan Chen; Junjie Bai; Hao Shi; Tianxiang Zheng; Meizhou Huang; Wenguang Fu
Journal:  J Agric Food Chem       Date:  2022-09-26       Impact factor: 5.895

6.  Effects of total parenteral nutrition on drug metabolism gene expression in mice.

Authors:  Christina Ferrucci-Da Silva; Le Zhan; Jianliang Shen; Bo Kong; Michael J Campbell; Naureen Memon; Thomas Hegyi; Lucy Lu; Grace L Guo
Journal:  Acta Pharm Sin B       Date:  2019-11-06       Impact factor: 11.413

Review 7.  Bile Acids and GPBAR-1: Dynamic Interaction Involving Genes, Environment and Gut Microbiome.

Authors:  Piero Portincasa; Agostino Di Ciaula; Gabriella Garruti; Mirco Vacca; Maria De Angelis; David Q-H Wang
Journal:  Nutrients       Date:  2020-11-30       Impact factor: 5.717

8.  TGR5 controls bile acid composition and gallbladder function to protect the liver from bile acid overload.

Authors:  Valeska Bidault-Jourdainne; Grégory Merlen; Mathilde Glénisson; Isabelle Doignon; Isabelle Garcin; Noémie Péan; Raphael Boisgard; José Ursic-Bedoya; Matteo Serino; Christoph Ullmer; Lydie Humbert; Ahmed Abdelrafee; Nicolas Golse; Eric Vibert; Jean-Charles Duclos-Vallée; Dominique Rainteau; Thierry Tordjmann
Journal:  JHEP Rep       Date:  2020-11-11

9.  Gypenosides regulate farnesoid X receptor-mediated bile acid and lipid metabolism in a mouse model of non-alcoholic steatohepatitis.

Authors:  Hongshan Li; Yingfei Xi; Xin Xin; Huajie Tian; Yiyang Hu
Journal:  Nutr Metab (Lond)       Date:  2020-05-01       Impact factor: 4.169

Review 10.  A Perspective Of Intestinal Immune-Microbiome Interactions In Alcohol-Associated Liver Disease.

Authors:  Ryan Bruellman; Cristina Llorente
Journal:  Int J Biol Sci       Date:  2021-01-01       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.